Zentalis Pharmaceuticals, Inc. · NASDAQ:ZNTL
Eventide Asset Management, LLC's stake in Zentalis Pharmaceuticals, Inc. fell below 5% (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Eventide Asset Management, LLC's stake in Zentalis Pharmaceuticals, Inc. fell below 5%, 0 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 0%
- Shares
- 0
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Eventide Asset Management, LLC | 0% | 0 |
| Finny Kuruvilla, M.D. Ph. D. | 0% | 0 |
| Robin C. John | 0% | 0 |
Source
Related
- Zentalis Pharmaceuticals, Inc.
- Eventide Asset Management, LLC
- Zentalis Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Eventide Asset Management, LLC · May 13, 2025
- Schedule 13G/A · Eventide Asset Management, LLC · Feb 14, 2025
- Form 4 · Bruns Ingmar · Oct 1, 2026
- Form 4 · Walters William Thurman · Aug 19, 2026
- Schedule 13G/A · Walters Group · Aug 19, 2026
- Schedule 13G/A · Barclays PLC · Aug 13, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026